Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1995 Mar;71(3):529–536. doi: 10.1038/bjc.1995.105

Detection of hypoxia by measurement of DNA damage in individual cells from spheroids and murine tumours exposed to bioreductive drugs. I. Tirapazamine.

P L Olive 1
PMCID: PMC2033654  PMID: 7880735

Abstract

The possibility of using tirapazamine (SR 4233) to identify hypoxic cells in multicell spheroids and murine tumours was examined by measuring tirapazamine-induced DNA damage to individual cells from multicell spheroids and SCCVII murine tumours. Fluorescence microscopy and image analysis were used to measure the extent of migration of DNA from individual cells embedded in agarose and exposed to an electric field. Using both the alkaline and neutral versions of the comet assay, at least 20 times more single-strand breaks were observed in cells from fully anoxic than fully oxic Chinese hamster V79 spheroids exposed to 30 microM tirapazamine, and about 10 times more single- than double-strand breaks were observed. Cells from spheroids containing about 50% radiobiologically hypoxic cells showed a pattern of tirapazamine breaks which translated to approximately 30% well-oxygenated in SCCVII tumors growing in C3H mice was also demonstrated. Cells close to tumour blood vessels showed less DNA damage by 20 mg kg-1 tirapazamine than cells distant from blood vessels. Rejoining of single-strand breaks was exponential, with a half-time of about 1 h under aerobic conditions, but rejoining half-time increased to 2 h for cells allowed to repair under anoxic conditions. While tirapazamine damage to DNA measured using the comet assay cannot provide a direct measure of hypoxic fraction, the degree of heterogeneity in DNA damage can be used to estimate the range and distribution of individual cell oxygen contents within spheroids and tumours.

Full text

PDF
529

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Biedermann K. A., Wang J., Graham R. P., Brown J. M. SR 4233 cytotoxicity and metabolism in DNA repair-competent and repair-deficient cell cultures. Br J Cancer. 1991 Mar;63(3):358–362. doi: 10.1038/bjc.1991.85. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bremner J. C., Stratford I. J., Bowler J., Adams G. E. Bioreductive drugs and the selective induction of tumour hypoxia. Br J Cancer. 1990 May;61(5):717–721. doi: 10.1038/bjc.1990.161. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brown J. M. SR 4233 (tirapazamine): a new anticancer drug exploiting hypoxia in solid tumours. Br J Cancer. 1993 Jun;67(6):1163–1170. doi: 10.1038/bjc.1993.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bush R. S., Jenkin R. D., Allt W. E., Beale F. A., Bean H., Dembo A. J., Pringle J. F. Definitive evidence for hypoxic cells influencing cure in cancer therapy. Br J Cancer Suppl. 1978 Jun;3:302–306. [PMC free article] [PubMed] [Google Scholar]
  5. Cahill A., White I. N. Reductive metabolism of 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233) and the induction of unscheduled DNA synthesis in rat and human derived cell lines. Carcinogenesis. 1990 Aug;11(8):1407–1411. doi: 10.1093/carcin/11.8.1407. [DOI] [PubMed] [Google Scholar]
  6. Chaplin D. J., Olive P. L., Durand R. E. Intermittent blood flow in a murine tumor: radiobiological effects. Cancer Res. 1987 Jan 15;47(2):597–601. [PubMed] [Google Scholar]
  7. Chapman J. D., Dugle D. L., Reuvers A. P., Meeker B. E., Borsa J. Letter: Studies on the radiosensitizing effect of oxygen in Chinese hamster cells. Int J Radiat Biol Relat Stud Phys Chem Med. 1974 Oct;26(4):383–389. doi: 10.1080/09553007414551361. [DOI] [PubMed] [Google Scholar]
  8. Durand R. E., Olive P. L. Evaluation of bioreductive drugs in multicell spheroids. Int J Radiat Oncol Biol Phys. 1992;22(4):689–692. doi: 10.1016/0360-3016(92)90504-b. [DOI] [PubMed] [Google Scholar]
  9. Koch C. J. Unusual oxygen concentration dependence of toxicity of SR-4233, a hypoxic cell toxin. Cancer Res. 1993 Sep 1;53(17):3992–3997. [PubMed] [Google Scholar]
  10. Laderoute K., Wardman P., Rauth A. M. Molecular mechanisms for the hypoxia-dependent activation of 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233). Biochem Pharmacol. 1988 Apr 15;37(8):1487–1495. doi: 10.1016/0006-2952(88)90010-x. [DOI] [PubMed] [Google Scholar]
  11. Minchinton A. I., Lemmon M. J., Tracy M., Pollart D. J., Martinez A. P., Tosto L. M., Brown J. M. Second-generation 1,2,4-benzotriazine 1,4-di-N-oxide bioreductive anti-tumor agents: pharmacology and activity in vitro and in vivo. Int J Radiat Oncol Biol Phys. 1992;22(4):701–705. doi: 10.1016/0360-3016(92)90507-e. [DOI] [PubMed] [Google Scholar]
  12. Okunieff P., Hoeckel M., Dunphy E. P., Schlenger K., Knoop C., Vaupel P. Oxygen tension distributions are sufficient to explain the local response of human breast tumors treated with radiation alone. Int J Radiat Oncol Biol Phys. 1993 Jul 15;26(4):631–636. doi: 10.1016/0360-3016(93)90280-9. [DOI] [PubMed] [Google Scholar]
  13. Olive P. L., Banáth J. P. Detection of DNA double-strand breaks through the cell cycle after exposure to X-rays, bleomycin, etoposide and 125IdUrd. Int J Radiat Biol. 1993 Oct;64(4):349–358. doi: 10.1080/09553009314551531. [DOI] [PubMed] [Google Scholar]
  14. Olive P. L., Banáth J. P., Durand R. E. Heterogeneity in radiation-induced DNA damage and repair in tumor and normal cells measured using the "comet" assay. Radiat Res. 1990 Apr;122(1):86–94. [PubMed] [Google Scholar]
  15. Olive P. L., Banáth J. P., Evans H. H. Cell killing and DNA damage by etoposide in Chinese hamster V79 monolayers and spheroids: influence of growth kinetics, growth environment and DNA packaging. Br J Cancer. 1993 Mar;67(3):522–530. doi: 10.1038/bjc.1993.97. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Olive P. L., Banáth J. P., MacPhail H. S. Lack of a correlation between radiosensitivity and DNA double-strand break induction or rejoining in six human tumor cell lines. Cancer Res. 1994 Jul 15;54(14):3939–3946. [PubMed] [Google Scholar]
  17. Olive P. L. Distribution, oxygenation, and clonogenicity of macrophages in a murine tumor. Cancer Commun. 1989;1(2):93–100. doi: 10.3727/095535489820875273. [DOI] [PubMed] [Google Scholar]
  18. Olive P. L., Durand R. E. Detection of hypoxic cells in a murine tumor with the use of the comet assay. J Natl Cancer Inst. 1992 May 6;84(9):707–711. doi: 10.1093/jnci/84.9.707. [DOI] [PubMed] [Google Scholar]
  19. Olive P. L., Durand R. E., Le Riche J., Olivotto I. A., Jackson S. M. Gel electrophoresis of individual cells to quantify hypoxic fraction in human breast cancers. Cancer Res. 1993 Feb 15;53(4):733–736. [PubMed] [Google Scholar]
  20. Olive P. L. Radiation-induced reoxygenation in the SCCVII murine tumour: evidence for a decrease in oxygen consumption and an increase in tumour perfusion. Radiother Oncol. 1994 Jul;32(1):37–46. doi: 10.1016/0167-8140(94)90447-2. [DOI] [PubMed] [Google Scholar]
  21. Olive P. L., Vikse C. M., Durand R. E. Hypoxic fractions measured in murine tumors and normal tissues using the comet assay. Int J Radiat Oncol Biol Phys. 1994 Jun 15;29(3):487–491. doi: 10.1016/0360-3016(94)90443-x. [DOI] [PubMed] [Google Scholar]
  22. Olive P. L., Wlodek D., Banáth J. P. DNA double-strand breaks measured in individual cells subjected to gel electrophoresis. Cancer Res. 1991 Sep 1;51(17):4671–4676. [PubMed] [Google Scholar]
  23. Olive P. L., Wlodek D., Durand R. E., Banáth J. P. Factors influencing DNA migration from individual cells subjected to gel electrophoresis. Exp Cell Res. 1992 Feb;198(2):259–267. doi: 10.1016/0014-4827(92)90378-l. [DOI] [PubMed] [Google Scholar]
  24. Ostling O., Johanson K. J. Microelectrophoretic study of radiation-induced DNA damages in individual mammalian cells. Biochem Biophys Res Commun. 1984 Aug 30;123(1):291–298. doi: 10.1016/0006-291x(84)90411-x. [DOI] [PubMed] [Google Scholar]
  25. Stone H. B., Brown J. M., Phillips T. L., Sutherland R. M. Oxygen in human tumors: correlations between methods of measurement and response to therapy. Summary of a workshop held November 19-20, 1992, at the National Cancer Institute, Bethesda, Maryland. Radiat Res. 1993 Dec;136(3):422–434. [PubMed] [Google Scholar]
  26. Walton M. I., Workman P. Pharmacokinetics and bioreductive metabolism of the novel benzotriazine di-N-oxide hypoxic cell cytotoxin tirapazamine (WIN 59075; SR 4233; NSC 130181) in mice. J Pharmacol Exp Ther. 1993 May;265(2):938–947. [PubMed] [Google Scholar]
  27. Wang J., Biedermann K. A., Brown J. M. Repair of DNA and chromosome breaks in cells exposed to SR 4233 under hypoxia or to ionizing radiation. Cancer Res. 1992 Aug 15;52(16):4473–4477. [PubMed] [Google Scholar]
  28. Wang J., Biedermann K. A., Wolf C. R., Brown J. M. Metabolism of the bioreductive cytotoxin SR 4233 by tumour cells: enzymatic studies. Br J Cancer. 1993 Feb;67(2):321–325. doi: 10.1038/bjc.1993.59. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Ward J. F. Some biochemical consequences of the spatial distribution of ionizing radiation-produced free radicals. Radiat Res. 1981 May;86(2):185–195. [PubMed] [Google Scholar]
  30. Zeman E. M., Brown J. M., Lemmon M. J., Hirst V. K., Lee W. W. SR-4233: a new bioreductive agent with high selective toxicity for hypoxic mammalian cells. Int J Radiat Oncol Biol Phys. 1986 Jul;12(7):1239–1242. doi: 10.1016/0360-3016(86)90267-1. [DOI] [PubMed] [Google Scholar]
  31. Zeman E. M., Brown J. M. Pre- and post-irradiation radiosensitization by SR 4233. Int J Radiat Oncol Biol Phys. 1989 Apr;16(4):967–971. doi: 10.1016/0360-3016(89)90897-3. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES